AFP and neoplasm: Follow-up protocols as per the European Guidelines include regular clinical examinations and tumor marker assessments (AFP, β-hCG, and LDH) at defined intervals - every three months during year 1, every four months in year 2, every six months until year 5, and annually thereafter.